Low-dose Colchicine Inhibit Abdominal Aortic Aneurysm Growth Trial

NANot yet recruitingINTERVENTIONAL
Enrollment

230

Participants

Timeline

Start Date

June 1, 2022

Primary Completion Date

June 1, 2024

Study Completion Date

December 31, 2025

Conditions
ColchicineAbdominal Aortic AneurysmProgression
Interventions
DRUG

colchicine

colchicine 0.5mg per day for 24 months

DRUG

Placebo

placebo 0.5mg per day for 24 months

All Listed Sponsors
collaborator

The First Affiliated Hospital of Guangzhou Medical University

OTHER

collaborator

Shenzhen People's Hospital

OTHER

collaborator

Peking University Shougang Hospital

OTHER

collaborator

Peking Union Medical College Hospital

OTHER

collaborator

Second Xiangya Hospital of Central South University

OTHER

collaborator

Zhongshan People's Hospital, Guangdong, China

OTHER

collaborator

Shenzhen Bao an People's Hospital

UNKNOWN

lead

Guangdong Provincial People's Hospital

OTHER

NCT05361772 - Low-dose Colchicine Inhibit Abdominal Aortic Aneurysm Growth Trial | Biotech Hunter | Biotech Hunter